Cloning, expression and purification of the anion exchanger 1 homologue from the basidiomycete Phanerochaete chrysosporium. by Tokuda, Natsuko et al.
Title
Cloning, expression and purification of the anion exchanger 1
homologue from the basidiomycete Phanerochaete
chrysosporium.
Author(s)
Tokuda, Natsuko; Igarashi, Kiyohiko; Shimamura, Tatsuro;
Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Ito, Keisuke;
Sugawara, Taishi; Asada, Hidetsugu; Murata, Takeshi;
Nomura, Norimichi; Iwata, So; Kobayashi, Takuya
CitationProtein expression and purification (2011), 79(1): 81-87
Issue Date2011-09
URL http://hdl.handle.net/2433/143680






Cloning, expression and purification of the anion exchanger 1 

























a, c, e, f, *, Takuya Kobayashi
a, c, * 
 
a
Department of Medical Chemistry, Kyoto University Faculty of Medicine, Konoe-cho, 
Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. 
 
b
Department of Biomaterials Sciences, Graduate School of Agricultural and Life 
Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan. 
 
c
Iwata Human Receptor Crystallography project, ERATO, JST, Konoe-cho, Yoshida, 
Sakyo-ku, Kyoto 606-8501, Japan. 
 
d
Department of Applied Biological Chemistry, Graduate School of Agricultural and 
Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan. 
 
e




Membrane Protein Crystallography Group, Division of Molecular Biosciences, 
Imperial College London, SW7 2AZ, UK,  
 
Key words: Anion exchanger; Pichia pastoris; cloning; purification; Phanerochaete 
chrysosporium 
 





*Corresponding author: So Iwata 
Fax: +81-75-751-8263 
Tel: +81-75-753-4372 








Anion exchangers are membrane proteins that have been identified in a wide 




 across the cell membrane. In this 
study, we cloned an anion-exchange protein from the genome of the basidiomycete 
Phanerochaete chrysosporium (PcAEP). PcAEP is a 618-amino acid protein that is 
homologous to the human anion exchanger (AE1) with 22.9% identity and 40.3% 
similarity. PcAEP was overexpressed by introducing the PcAEP gene into the genome 
of Pichia pastoris. As a result, PcAEP localized in the membrane of P. pastoris and was 
solubilized successfully by n-dodecyl-β-D-maltoside. His-tagged PcAEP was purified 
as a single band on SDS-PAGE with monodispersity using immobilized metal affinity 
chromatography and gel filtration chromatography. Purified PcAEP was found to bind 
to SITS, an inhibitor of the AE family, suggesting that the purified protein is folded 
properly. PcAEP expressed and purified using the present system could be useful for 
biological and structural studies of the anion exchange family of proteins. 
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Introduction 
Anion exchangers are membrane proteins that have been identified in a wide 
variety of species (e.g., human [1], mouse [2], rat [3], chicken [4], trout [5], yeast [6], 




 across the membrane 
to maintain intracellular pH levels [8]. In human, AE1 is found primarily in erythrocytes 
and kidney. Human AE1 is a glycoprotein comprised of 2 distinct domains: the 
cytoplasmic N-terminal ~40 kDa domain contains binding sites for cytoskeletal and 
cytoplasmic proteins, and the membrane-embedded C-terminal ~55 kDa domain 
mediates anion exchange [9-11]. Mutations in the C-terminal domain are known to 
cause diseases such as human distal renal tubular acidosis [12]. 
AE1 transports several kinds of anions with a variety of sizes and charge 













 [13,14]. This activity can be inhibited specifically by stilbene disulfonate 
inhibitors [14]. To elucidate these mechanisms of anion exchange in detail, it is essential 
to know structural information about AE1. However, the crystal structure of AE1 
remains unknown, due to the difficulties in its crystallization. Generally, large quantities 
of pure protein are required to obtain diffracting crystals. Recombinant human AE1 has 
been expressed at relatively high levels in the yeast Saccharomyces cerevisiae [15]; 
however, the purity of the recombinant protein was insufficient for crystallization. A 
His-tagged form of the AE1 homologue in S. cerevisiae (YNL275w) also has been 
expressed in the yeast, but the resulting expression levels were low [6]. 
In this report, we successfully constructed an overexpression system for the 
basidiomycete Phanerochaete chrysosporium Anion-Exchange Protein (PcAEP) that 
shows sequence similarities to human AE1 and yeast YNL275w. His-tagged PcAEP was 
highly expressed in Pichia pastoris and purified by metal affinity chromatography and 
gel filtration. The structural integrity of the purified protein was assessed by the binding 
of a stilbene disulfonate AE1 inhibitor, SITS (4-acetamido-4'-isothiocyano-2,2'-stilbene 
disulphonic acid) [14].  
 
Materials and Methods 
Strains 
P. chrysosporium strain K-3 [16] was used as a source for the target gene. 
Escherichia coli strain JM109 (Takara Bio, Shiga, Japan) and P. pastoris strain 
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SMD1168H (Invitrogen, Carlsbad, CA) were used for subcloning and heterologous 
production of the recombinant protein, respectively.  
Cloning of the cDNA encoding PcAEP 
P. chrysosporium was grown in Kremer and Wood medium [17] containing 2% 
glucose or cellulose (CF11; Whatman, Fairfield, NJ, USA) as the sole carbon source, as 
described previously [18]. After culturing for 3 d, mycelia were collected using a glass 
filter membrane (ADVANTEC
®
 GA-100; Toyo Roshi Kaisha, Tokyo, Japan) and frozen 
in liquid nitrogen. Total RNA was extracted from approximately 200 mg of frozen 
mycelial powder using ISOGEN (Nippon Gene, Tokyo, Japan). The mRNA was 
purified from 1 µg of total RNA extracted with Oligotex™-dT30<Super> (Takara Bio) 
using ReverTraAce (Toyobo, Osaka, Japan) and a 3’ RACE adaptor primer (Invitrogen). 
First-strand cDNA was synthesized from the mRNA.  
The gene encoding PcAEP was identified in a search of the P. chrysosporium 
genome database (http://genome.jgi-psf.org/Phchr1/Phchr1.home.html) using the amino 
acid sequence of YNL275w, an anion exchanger from S. cerevisiae (NCBI accession 
number Z71551). Oligonucleotide primers for the amplification of the cDNA fragment 
encoding PcAEP (Pcaep) were designed based on the genomic sequence 
(e_gwh2.17.21.1), as follows: Pcaep-F: 5’-TTTATGTCAA ACGTTACATC 
GCGCACC-3’, and Pcaep-R: 5’-TTTCTAGTGT ATGCCCCCGA CGGATTC-3’. PCR 





 PCR cloning kit and E. coli JM109. Sequencing was performed 
using a BigDye Terminator v3.1 cycle sequencing kit with an automated DNA 
sequencer (ABI PRISM 3100 Genetic analyzer, Applied Biosystems, Foster, CA, USA). 
The nucleotide sequence was submitted to the DDBJ/EMBL/GenBank databases under 
accession number AB444853. 
Transformation of cDNA encoding PcAEP 
The PcAEP gene was isolated from the TOPO vector by digestion with SfuI and 
NotI. The isolated fragment was ligated into the pPICZ A plasmid (Invitrogen) 
pretreated with SfuI and NotI. FLAG- and His-tags were introduced at the C-terminus of 
PcAEP. The pPICZ A plasmid containing PcAEP was linearized with PmeI (New 
England Biolabs, Ipswich, MA, USA). The linearized plasmid was transformed into the 
genome of the methylotropic yeast P. pastoris SMD1168H by electroporation using the 
Gene Pulser Xcell system (Bio-Rad, Hercules, CA).  
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Transformants were plated on YPDS plates (1% yeast extract, 2% peptone, 2% 
dextrose, 1 M sorbitol, and 2% agar) containing 100 µg/mL zeocin and were screened 
by zeocin resistance. Positive clones were cultured and induced to produce PcAEP. 
Protein expression was examined by Western blotting. Selected transformants highly 
expressing PcAEP were stored as glycerol stocks at -80 ºC. 
Culture of PcAEP transformants 
Selected clones were grown in BMGY (Buffered Glycerol-complex Medium, 
1% yeast extract, 2% peptone, 100 mM potassium phosphate, pH 6.0, 1.34% yeast 
nitrogen base without amino acids, 4 × 10
-5
% biotin and 1% glycerol) at 30 °C 
overnight. Cultures were diluted 4-fold in BMGY and cultured for 4–6 h. The cells were 
harvested by centrifugation at 4000 g for 15 min and induced to express PcAEP in 
BMMY (Buffered Methanol-complex Medium, 1% yeast extract, 2% peptone, 100 mM 
potassium phosphate, pH 7.0, 1.34% yeast nitrogen base without amino acids, 4 × 10
-5
% 
biotin, 3% DMSO, 4% histidine, and 0.5% methanol) at 20 °C for 20 h. The cells were 
harvested by centrifugation at 4000 g for 15 min. 
Different temperatures (20 and 30 °C) and induction times (20, 40, or 60 h) were 
tested to optimize the culture conditions. 
Immunofluorescence microscopy 
Unless otherwise noted, the following steps were performed at room 
temperature. PcAEP-expressing cells were washed with PBS buffer (pH 7.4), fixed with 
4% paraformaldehyde for 2 h, and washed thrice with PBS. The fixed cells were gently 
incubated with 0.2% zymolyase-100T (Seikagaku Biobusiness Corp., Tokyo, Japan) at 
35 °C for 2 h to remove the cell wall. The cells were washed with PBS, followed by 
permeabilization with 3% NP-40 and 10% DMSO in PBS for 30 min. Permeabilized 
cells were blocked overnight with 5% BSA in PBS at 4 °C. BSA-treated cells were 
incubated with primary antibody (1:300 anti-polyhistidine mAb; Sigma-Aldrich) 
followed by secondary antibody (1:300 Alexa Fluor 488; Invitrogen) in PBS containing 
5% BSA for 1.5 h. The cells were washed with PBS, attached to a slide glass, and 
observed with a spectral confocal scanning system (LEICA, Solms, Germany). 
Membrane preparation, solubilization and protein purification 
Cell pellets (1 g) were resuspended in 3 mL of buffer A (50 mM sodium 
phosphate, pH 7.4, 100 mM NaCl, 5% glycerol, 2 mM EDTA, and protease inhibitor 
cocktail (Complete EDTA-free, Roche Applied Science, Mannheim, Germany)). Cells 
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were disrupted by vigorous agitation in the presence of glass beads at 4 °C for 2 h. After 
centrifugation at 2,000 g for 10 min to remove cell debris, the supernatant was 
centrifuged at 100,000 g for 45 min. The membrane pellet was collected and 
homogenized in buffer B (50 mM Tris-HCl, pH 8.0, 120 mM NaCl, 20% glycerol, and 
Complete EDTA-free protease inhibitor cocktail). The final protein concentration, 
estimated by bicinchoninic acid (BCA) assay (Pierce, Rockford, IL, USA), was adjusted 
to 10 mg/mL with buffer C (20 mM Hepes, pH 7.0, 500 mM NaCl, 30% glycerol).  
The membranes were solubilized with 1% n-dodecyl-β-D-maltoside (DDM, 
Anatrace, OH, USA) and 0.2% cholesteryl hemisuccinate (Sigma-Aldrich) at 4 °C for 1 
h. The solution was centrifuged at 100,000 g for 45 min to remove insoluble material. 
Solubilized protein (300 mg) was mixed with 1 mL of TALON™ metal affinity resin 
(Clontech, Palo Alto, CA, USA) in 20 mM imidazole. After incubation on a rotary 
wheel at 4 °C overnight, the resin was collected by centrifugation and washed with 50 
mL of buffer D (20 mM Hepes, pH 7.0, 250 mM NaCl, 10% glycerol, 0.05% DDM and 
0.01% cholesteryl hemisuccinate) containing 20 mM imidazole. Bound proteins were 
then eluted with 6 mL of buffer D containing 167 mM imidazole. 
The eluted fractions were pooled, concentrated, and loaded onto a Superdex 200 
10/300 column (GE Healthcare, Tokyo, Japan). The main peak fractions were loaded 
onto a second Superdex 200 10/300 column. The fraction corresponding to PcAEP was 
analyzed by Coomassie staining. At the gel-filtration chromatography step, the column 
was preequilibrated with the running buffer (20 mM Hepes, pH 7.0, 150 mM NaCl, 
0.05% DDM) and the flow rate was 0.3 mL/min. 
SITS Affi-gel binding assay 
A SITS Affi-gel binding assay was performed as described previously 
[6,12,19,20]. Purified 0.1 µg/µl PcAEP (2 μL aliquot) was incubated with 50 µl SITS 
Affi-gel resin in 100 µL citrate buffer (0.1% DDM, 250 mM sodium citrate, pH 7.1) at 
4 °C for 30 min. The resin was collected by centrifugation and the supernatant (unbound 
fraction) was removed. The collected resin was washed thrice with 0.5 mL of citrate 
buffer. The protein bound to the SITS Affi-gel (bound fraction) was released from the 
resin with 50 µL of SDS sample buffer (Invitrogen) at room temperature. Both unbound 
and bound fractions were analyzed by Western blotting. 
 
 7 
Results and Discussion 
“Figure 1 near here” 
Cloning of PcAEP cDNA encoding PcAEP 
The basidiomycete P. chrysosporium was found to carry one gene 
(e_gwh2.17.21.1) encoding a hypothetical anion exchange protein, as determined in a 
genome database search of P. chrysosporium 
(http://genome.jgi-psf.org/Phchr1/Phchr1.home.html) [21]. As shown in Fig. 1, PcAEP 
has homology to human AE1 (band 3) and S. cerevisiae YNL275w [6]. The cDNA of 
the P. chrysosporium Anion-Exchange Protein (PcAEP) was successfully cloned from a 
P. chrysosporium cDNA library and consisted of an 1854-nt open reading frame 
encoding a 618-amino acid protein.  
Sequence alignment 
A BLAST search of the NCBI database 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) using the blastp algorithm detected 
sequences homologous to PcAEP in other species. The polypeptide consists of 618 
amino acid residues with an estimated molecular weight of 68,644.55. The amino acid 
identities and similarities between PcAEP and human AE1 or yeast YNL275w were 
estimated to be 22.9% and 37.8%, and 40.3% and 53.4%, respectively, using the server 
in http://www.ebi.ac.uk/Tools/emboss/align/index.html. 
High-mannose oligosaccharides attach to Asn-X-Thr/Ser (X, any amino acid 
other than Pro) acceptor sites [22, 23]. PcAEP has 4 Asn-X-Thr/Ser motifs at Asn3, 
Asn148, Asn295, and Asn344 (Fig. 1). None of these sites correspond to the 
N-glycosylation site of human AE1 (Asn642). Of the 4 Asn residues, 3 residues (Asn3, 
Asn148, and Asn344) are conserved in YNL275w, which was characterized previously 
as a non-glycosylated protein [6]. PcAEP was not detected in glycoprotein staining after 
electrophoresis (data not shown). Given these considerations, PcAEP is not likely to be 
glycosylated. 
 
“Figure 2 near here” 
PcAEP expression and solubilization 
To confirm the expression of PcAEP in P. pastoris, each fraction was 
separated by SDS-PAGE and analyzed by Coomassie staining (Fig. 2A) and Western 
blotting (Fig. 2B). PcAEP was difficult to detect by Coomassie staining. PcAEP was 
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detected in the membrane fraction (lane 7) by immunostaining, but not in the soluble 
fraction (lane 6), indicating that PcAEP is expressed as a membrane protein. A band 
corresponding to PcAEP was not detected in untransformed cells (lanes 1-4). PcAEP 
was detected in the solubilized membrane fraction (lane 8), indicating that PcAEP was 
successfully solubilized by 1% DDM and 0.2% cholesteryl hemisuccinate.  
 
“Figure 3 near here” 
Optimization of culture conditions 
We examined the effects of the induction temperature and culture time on the 
PcAEP expression level. Cells were cultured at 20 or 30 °C for 20, 40, or 60 h during 
induction, and the expression levels were analyzed by Western blotting (Fig. 3). PcAEP 
was degraded under all conditions except for the 20-h induction at 20 °C. Therefore, 
this condition was used throughout the paper for the induction of PcAEP expression.  
 
“Fig. 4 near here” 
Plasma membrane localization of PcAEP 
The plasma membrane localization of PcAEP was confirmed by 
immunofluorescence. PcAEP was detected at the plasma membrane in transformed cells 
after permeabilization with NP-40 (Fig. 4e, f), which indicates that PcAEP is properly 
folded and transported to the plasma membrane. When the cells were immunolabeled 
without NP-40, no signal could be detected (Fig. 4b, c). These results indicate that the 
N- and C-termini of PcAEP locate in the cytosol, similar to the predicted localizations 
for human AE1 [9] and YNL275w [6]. 
 
“Fig. 5, 6, Table1 near here” 
Purification of PcAEP 
The solubilized membrane fraction was subjected to TALON™ metal affinity 
chromatography. Although PcAEP was not detected by Coomassie staining of the 
solubilized membrane fraction (Fig. 5, lane 1), a major band of PcAEP appeared in the 
fraction eluted from the TALON™ resin (lane 4). The eluted PcAEP was further 
purified using Superdex 200 (Fig. 6). Analysis by SDS-PAGE revealed that the main 
peak corresponded to highly purified PcAEP. As previously reported [25, 26, 27], a 
monomeric monodisperse folded protein generally yields a single symmetrical peak that 
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may be suitable for crystallization, which suggests that purified PcAEP is a potential 
target for crystallization. 
From a 1-L culture, 1.5 mg of highly purified PcAEP was obtained, which is 
more than the yields of recombinant human AE1 (0.7 mg partially purified protein from 
1 L culture) [15] and yeast YNL275w expressed in S. cerevisiae (0.1 mg from 1 L 
culture) [6]. Our expression and purification system for PcAEP will be an important tool 
for structural studies that require large quantities of the protein. 
 
“Fig. 7 near here” 
SITS Affi-gel binding assay 
 SITS is a potent inhibitor of anion exchangers. H2DIDS, which is an inhibitor 
that is similar to SITS, is known to react covalently with K539 and K851 of human AE1 
and SITS is presumed to also bind these sites (Fig. 1). To assess the structural integrity 
of the purified PcAEP, a SITS Affi-gel binding assay was performed for PcAEP, as was 
done previously for recombinant human AE1 [15] and YNL275w [6]. PcAEP was 
detected in the bound fraction when incubated with SITS-Affi gel (Fig. 7, lane 4), while 
the SITS-uncoupled Affi-gel did not bind PcAEP (lane 1). This result indicates that 




In summary, we have successfully cloned and purified PcAEP, an AE1 
homologue of the basidiomycete P. chrysosporium. The sequence similarity, membrane 
localization, and SITS-binding ability of PcAEP suggest that this protein is an anion 
transporter similar to human AE1. P. chrysosporium has a high optimal growth 
temperature (~39 °C) [16], which suggests that this protein could be more thermostable 
than AE1 from other species. This finding is intriguing because protein thermostability 
is an important advantage for protein crystallization. Indeed, structural determination of 
the turkey β1-adrenergic receptor was successfully completed by improving the 
thermostability of the receptor through site-directed mutagenesis [28]. The A single 
symmetrical peak in size exclusion chromatography monodispersity of PcAEP also 
suggests that it is a good target for crystallization trials. 
The expression system described in this study is very suitable for the 
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crystallographic study of AE1, as well as for biochemical and biophysical analyses. The 
AE1 structure determined using our system may not only aid in elucidating the 
mechanisms underlying AE1 function, but also may be useful for studies of diseases 
caused by mutations of human AE1. 
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Figure Legends 
Fig. 1. Sequence alignment of PcAEP with the C-terminal transmembrane domain 
of human erythroid AE1 and yeast YNL275w. Sequences were aligned using the 
CLUSTALW web server (http://clustalw.ddbj.nig.ac.jp/top-j.html). (*) identical residues, 
(:) strongly similar residues, and (∙) weakly similar residues. The closed arrows indicate 
putative N-glycosylation acceptor sites (N-X-S/T, X≠P). The open arrow indicates the 
N-glycosylation acceptor site of human AE1. H2DIDS-binding lysines in human AE1 
are in red [24]. 
 
Fig. 2. PcAEP expression. Each lane contains ~20 µg of protein, as estimated using a 
BCA assay. Lanes 1, 5: whole cell extract; Lanes 2, 6: soluble fractions; Lanes 3, 7: 
membrane fractions; Lanes 4, 8: membrane fractions solubilized with 1% DDM, 0.2% 
cholesteryl hemisuccinate. Lanes 1-4: membranes from untransformed cells; Lanes 5-8: 
membranes from PcAEP transformed cells. (A) SDS-PAGE analysis. (B) Western 
blotting. The arrow indicates the band corresponding to the expressed PcAEP. 
 
Fig. 3. Optimization of the culture conditions. Membrane fractions were analyzed by 
Western blotting with the anti-FLAG-M2 antibody. Each lane contained ~7.5 µg of the 
membrane fraction, as estimated using a BCA assay. Lane 1: 20 °C, 20 h; Lane 2: 20 °C, 
40 h; Lane 3: 20 °C, 60 h; Lane 4: 30 °C, 20 h; Lane 5: 30 °C, 40 h; and Lane 6: 30 °C, 
60 h. Arrow indicates PcAEP.  
 
Fig. 4. Immunofluorescence staining of yeast cells. a-c: Nonpermeabilized cells; d-f: 
NP-40–permeabilized cells; a, d: Untransformed cells; b, e: N-terminal His-tagged 
PcAEP-transformed cells; c, f: C-terminal His-tagged PcAEP-transformed cells. Left: 
Bright-field image; Right: fluorescence image. 
 
Fig. 5. Purification of PcAEP using TALON metal affinity resin. All fractions were 
analyzed by SDS-PAGE. Lane 1, solubilized membranes with 1% DDM, 0.2% 
cholesteryl hemisuccinate; Lane 2, unbound fraction; Lane 3, wash fraction; and Lane 4, 
eluted fraction. Arrow indicates PcAEP.  
 
Fig. 6. Purification of TALON-purified PcAEP with gel filtration. SDS-PAGE 
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analysis of the main peak corresponding to PcAEP that was eluted from the Superdex 
200 column. Arrow indicates the band corresponding to PcAEP. 
 
Fig. 7. SITS Affi-gel binding assay. Purified PcAEP was incubated with SITS Affi-gel. 
The bound protein was eluted with SDS sample buffer. Lanes 1, 2: PcAEP was 
incubated with Affi-gel without SITS (negative control). Lanes 3, 4: PcAEP was 






































 PcAEP          MSNVTSRTATP---TPARALSVEGAQGGKPAQVPRSPSATVVDRSPNRFLLWAQSISIGR
 YNL275w        MSNESTRVTVSRGCTASDECAQALERTNDELDRESSVSESRSDEESHEKLSRRRFPTLGI
 hAE1           ----------------------------KGLDLNGGPDDPLQQTG-----------QLFG
                                            .  :   . . .  :              :  
 PcAEP          GIIHDIRRRAPYYVSDWTDAWNYRVIPAVVLIFFANVLPGIAFSLDLIETTQ-QYGVAEV
 YNL275w        GIWLDLKDRIPYYKSDWVDAFNYRVIPSIVDTYFNNLLPAIAFAQDMFDRTDNSYGVNEV
 hAE1           GLVRDIRRRYPYYLSDITDAFSPQVLAAVIFIYFAALSPAITFGGLLGEKTRNQMGVSEL
                *:  *:: * *** ** .**:. :*:.:::  :*  : *.*:*.  : : *  . ** *:
 PcAEP          LLSSFMAAFIFSVFGAQPLCIAGVTGPITVLNKTIYDIIERQDNPPNYLQFVGWVYLWGA
 YNL275w        LLSSAMAGIVFGVLGGQPLCIVGVTGPISIFNYTVYEIIKPLN--TSYFGFMFWICMWSM
 hAE1           LISTAVQGILFALLGAQPLLVVGFSGPLLVFEEAFFSFCETNG--LEYIVGRVWIGFWLI
                *:*: : .::*.::*.*** :.*.:**: ::: :.:.: :  .   .*:    *: :*  
 PcAEP          ILHWITAALNWCNFLRYVTLFSCDTFGFYVSWVYLQYGVQVITRQFPTPSSPPEDSQDGA
 YNL275w        IFHLVLAFTNAVCLLQYVTTFPCDIFGLFINVVYIQKGIQILTRQFSAKSG--EKSVQDG
 hAE1           LLVVLVVAFEGSFLVRFISRYTQEIFSFLISLIFIYETFSKLIKIFQDHPLQKTYNYNVL
                ::  : .  :   :::::: :. : *.: :. :::   .. : : *   .     . :  
 PcAEP          FVG---------IILALLMVG----SSYLFRTASQSPYFHRHVRRFFADYGMPLSLVAAS
 YNL275w        FAS---------VVVALVMTA----FGLFFKLFHYYPLFSHRIRTFISDYSTALSVLFWS
 hAE1           MVPKPQGPLPNTALLSLVLMAGTFFFAMMLRKFKNSSYFPGKLRRVIGDFGVPISILIMV
                :.           :::*:: .     . :::     . *  ::* .:.*:. .:*::   
 PcAEP          AMAYWG-RFNHANPTTLPVGKAFQPAGNREWLVRFWQLDG----KWVGIAFPFGFALWVL
 YNL275w        SFTHFGGYLHDVKFKKLPITKAFFPTSKVNRPQNTWLAYEPIPVKDVFIALPFGIFLTIL
 hAE1           LVDFFIQDTYTQKLS-VPDGFKVSNSSARGWVIHPLGLRSEFPIWMMFASALPALLVFIL
                 . .:       : . :*    .  :.      .            :  :   .: : :*
 PcAEP          FFFDHNVSSLMAQGSQFPLRKPPGFHYDFFILGITTFIAGLLGIPAPNGLIPQAPIHTES
 YNL275w        FYFDHNVSSLMAQRHQYKLKKPSSFHYDFALLGLTTCISGVLGIPAPNGLIPQAPLHTET
 hAE1           IFLESQITTLIVSKPERKMVKGSGFHLDLLLVVGMGGVAALFGMPWLSATTVRSVTHANA
                :::: ::::*:..  :  : * ..** *: ::     ::.::*:*  ..   ::  *:::
 PcAEP          LLIMESTHKKLDDIETPSRSREKTPSQPHELGTALAPVHMSRFQEELEPDPTLARDGDGE
 YNL275w        LLVRDSNQK---------------------------------------------------
 hAE1           LTVMGKASTPG-------------------------------------------------
                * :  .  .                                                   
 PcAEP          ARQHERPVAVVEQRVSNLAQGSLCLVLLSGPFLHVLNLIPRGVLAGLFWYMGLDALEGNG
 YNL275w        ------VISCVEQRFTNTFQGLMILGTMTRPLLVCLGEIPQAVLSGLFFIMGINGLMTNS
 hAE1           --AAAQIQEVKEQRISGLLVAVLVG--LSILMEPILSRIPLAVLFGIFLYMGVTSLSGIQ
                           ***.:.   . :    ::  :   *. ** .** *:*  **: .*    
 PcAEP          ITRKLLYFLRDKSLTPKDEPLRNVRKSRILLFVAVQLAAFGATMAVTQTIAAIGFPIIIM
 YNL275w        IIQRLVFLFSDPNRRDNTSPLMKVSKKSMLIFLSFSLTGFAGEFAITNTIAAIGFPLVLL
 hAE1           LFDRILLLFKPPKYHPDVPYVKRVKTWRMHLFTGIQIICLAVLWVVKSTPASLALPFVLI
                :  ::: ::   .   .   : .* .  : :* ...:  :.   .:..* *::.:*::::
 PcAEP          LLVPIRTLLIPRLPFTAEELSILDGPTASPFTMESVGGIH------------
 YNL275w        LSVLVS--FSFAYIFPTEELKILDTNVAQKFTIKNLLLENIRDAKFCDKHED
 hAE1           LTVPLRR-VLLPLIFRNVELQCLDADDAKATFDEEEGRDEYDEVAMPV----
                * * :   .     *   **. **   *.    :.    .            
BkDa
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